Subscribe free

Upper Gastrointestinal Tract ·

Neoadjuvant Chemoimmunotherapy Improves Survival in Esophageal Cancer

In patients with locally advanced esophageal squamous cell carcinoma, neoadjuvant chemoimmunotherapy (ncit) significantly improves three-year overall survival compared to standard chemoradiotherapy (ncrt).

  • Three-year overall survival rate was 79.7% for ncit versus 68.2% for ncrt (HR 0.51, p = 0.023).
  • ncit also showed lower rates of overall recurrence (15.8% vs 28.8%, p = 0.033) and distant metastases (6.6% vs 17.0%, p = 0.006) within two years postoperatively.

Surgeons may consider ncit as a preferable neoadjuvant strategy for enhancing long-term outcomes in eligible patients.

Journal Article by Ao Y, Leng C (…) Fu J et 9 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Upper Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Upper Gastrointestinal Tract

The latest stitches

Ann Surg Oncol2 Nov 2026

High symptom burden after oesophagectomy

On postoperative day 3, about one in five patients had high symptom burden, and the symptoms most linked to others differed between patient groups.

J Gastrointest Cancer23 Oct 2026

Uniportal esophagectomy linked to fewer pneumonias

In nine comparative studies of minimally invasive esophagectomy for esophageal cancer, uniportal VATS was associated with less pneumonia and a shorter stay than multiportal VATS—but the evidence is not strong enough to establish a preferred approach.

All papers in Upper Gastrointestinal Tract →